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A fundamental tenet of the “disconnectivity” theories of schizophrenia is that the disorder is ultimately caused by abnormal
communication between spatially disparate brain structures. Given that the white matter fasciculi represent the primary infras-
tructure for long distance communication in the brain, abnormalities in these ﬁber bundles have been implicated in the etiology of
schizophrenia. Diﬀusion tensor imaging (DTI) is a magnetic resonance imaging (MRI) technique that enables the visualization of
white matter macrostructure in vivo, and which has provided unprecedented insight into the existence and nature of white matter
abnormalities in schizophrenia. The paper begins with an overview of DTI and more commonly used diﬀusion metrics and moves
on to a brief review of the schizophrenia literature. The functional implications of white matter abnormalities are considered,
particularly with respect to myelin’s role in modulating the transmission velocity of neural discharges. The paper concludes with a
speculative hypothesis about the relationship between gray and white matter abnormalities associated with schizophrenia.
1.Introduction
A notable feature of the neuroimaging literature in schizo-
phrenia is the sheer number of brain structures that have
been implicated as abnormal in patients with this disorder.
The temporal cortices, medial temporal structures, and fron-
tal lobes have consistently been shown to be morphologically
and cytoarchitecturally abnormal in patients with schizo-
phrenia, and abnormalities in the parietal and cingulate
cortices, basal ganglia, and cerebellum are also common [1].
However, despite the multitude of gray matter (GM) struc-
turesthathavebeenreportedtobestructurallycompromised
in patients with schizophrenia, it is notable that there are
still no reliable biomarkers for the disease—in contrast, for
example, to the amyloid plaques and neuroﬁbrillary tangles
that are prognostic for Alzheimer’s disease. Furthermore, it
is also notable that while GM abnormalities are ubiquitous
in schizophrenia, there is no GM structure that is universally
atypical in patients with the disease, or to which damage has
consistently been shown to trigger psychotic symptoms [2].
Possibly in response to the ongoing failure to identify
a distinctive neuropathological signature for the disorder,
there has been a movement away from the idea that
schizophrenia iscausedbyafocalneuralinsultinfavorofthe
idea that schizophrenia arises from abnormal neural com-
munication. The fundamental tenet of the “disconnectivity”
theories of schizophrenia is that rather than being caused
by normal interactions between pathologic GM structures,
the symptoms of schizophrenia instead arise from patho-
logic interactions between pathologic GM structures [3].2 Schizophrenia Research and Treatment
For example, Frith [4] has suggested that delusions of
control could arise because of disrupted communication
between frontal areas initiating movement and parietal areas
processing the sensory consequences of that movement.
Crow [5], on the other hand, has suggested that auditory
hallucinations could arise from aberrant communication
between language-related regions in the temporal cortices,
bilaterally. Furthermore, while some “disconnectivity” the-
ories have emphasized the role of aberrant synaptic plasticity
intheetiologyofschizophrenia[6,7],othershavefocusedon
the role of structural abnormalities in the ﬁbers connecting
spatiallydisparate populations ofneurons—that is,thewhite
matter (WM).
WM is primarily constituted of the phospholipid pro-
cesses of oligodendrocytes, which are a class of neuroglia.
These processes, which are known as myelin, wrap around
axons in the central nervous system, insulating the mem-
brane and increasing the conduction velocity of action
potentials. Myelinated axons with similar destinations bun-
dle together into ﬁber tracts, and it is these ﬁber tracts that
constitute the infrastructure for long-distance communica-
tion between spatially disparate GM regions. In light of the
fact that ﬁber tract damage can disrupt or even disable com-
munication between connected brain regions [8], and given
that psychotic symptoms are unusually common in patients
with WM diseases (such as metachromatic leukodystrophy
[9] and multiple sclerosis [10]), a number of researchers
have speculated as to the existence and implications of WM
abnormalitiesinpatientswithschizophrenia,[2,11–14].The
results of genetic analyses that have revealed the abnormal
expression of several myelination-related genes in patients
withschizophrenia[15]havealsocontributedtoanincreased
interest into the role of WM abnormalities in the disorder.
While the basic idea that WM abnormalities could
underlie the symptoms of schizophrenia is not new (Bleuler
discussedthepossibilityin1911),ithasonlyrecentlybecome
the topic of focused empirical investigation. A major reason
for this is technical: WM is notoriously diﬃcult to measure
in vivo via conventional structural brain imaging techniques
such as magnetic resonance imaging (MRI) because of its
apparent homogeneity. Furthermore, imaging WM with
functional imaging techniques such as positron emission
tomography (PET) and functional MRI (fMRI) is also
problematic, due to the fact that the metabolic proﬁles
of oligodendrocytes are at least partially independent of
task-induced changes in neuron metabolism. And while
several in vitro stereologic studies have been undertaken
in schizophrenia patients postmortem, an acknowledged
disadvantage of the technique is the generally suboptimal
quality of the tissue, unless a postmortem can be arranged
quickly [16]. Given these methodological limitations, it is
fair to say that the development of diﬀusion tensor imaging
(DTI) in the 1980s [17] opened the door to the direct
empiricalinvestigationofWMabnormalitiesinpatientswith
schizophrenia,byenablinganaccuratequantiﬁcationofWM
integrity in vivo. An example of how DTI can be used to
identify speciﬁc WM ﬁber bundles (in this case, the corpus
callosum), based on their diﬀusion properties, is displayed in
Figure 1.
Figure 1: Fiber tractography of the corpus callosum (in gold) over-
laid onto a color-by-orientation image extracted from a Diﬀusion-
Tensor Image.
2. Diffusion Tensor Imaging—A Brief
Introduction
DTI enables inferences to be made in terms of the integrity
and orientation of ﬁber tracts on the basis of patterns of
water diﬀusion. DTI is noteworthy in that it can provide
information in terms of WM anatomy that is simply not
accessible with any other method—either in vivo or in
vitro.D i ﬀusion—otherwise known as Brownian motion—
refers to the random movement of particles, such as water
molecules, as a result of unpredictable, thermally driven
molecular collisions. In an unrestricted medium, a water
moleculeisequallylikelytomoveinonedirectionasanother.
However, in brain tissue the diﬀusion of water molecules
is restricted by obstacles in the local environment such as
cell membranes, myelin sheaths, and macromolecules. The
extent to which diﬀusion is restricted diﬀers between the
diﬀerenttissuesofthebrain.Inthecerebrospinalﬂuid(CSF),
for example, there are relatively few obstacles to diﬀusion,
and hence the average shape of the resultant diﬀusion is
approximately spherical: this is known as isotropic diﬀusion.
In contrast, in a WM ﬁber bundle the densely packed
and homogeneously oriented bundles of myelinated axons
provideaconsiderablebarriertowaterdiﬀusion.Inthiscase,
water is more likely to diﬀuse parallel to the WM bundle
rather than perpendicular to it, which will make the shape
of the resultant diﬀusion less spherical and more ellipsoidal:
this is known as anisotropic diﬀusion—see Figure 2.B y
calculating the distance in which water diﬀuses in a given
v o x e li nag i v e na m o u n to ft i m e( i . e . ,i nt h eo r d e ro f
milliseconds) for at least six noncollinear directions, it is
possible to reconstruct a three-dimensional shape that best
describes the pattern of water diﬀusion occurring in a given
voxel. The shape best describing this pattern of diﬀusion is
conventionally modeled as an ellipsoid, and the important
point is that the volume and shape of this ellipsoid provide
information about the diﬀusion properties and hence the
microstructural features of the brain tissue.Schizophrenia Research and Treatment 3
(a)
Interhemispheric ﬁssure
(isotropic diﬀusion)
Corpus callosum
(anisotropic diﬀusion)
(b)
Figure 2: The shape of water diﬀusion in the diﬀerent tissues of the brain. (a) depicts the variations in the shape of water diﬀusion across
a coronal slice of brain tissue, while (b) is a zoomed-in section of (a). As illustrated in (b), the shape of diﬀusion in the inter-hemispheric
ﬁssure is approximately spherical, as there are few obstacles to diﬀusion in the CSF. In contrast, the tightly aligned, myelinated ﬁbers of the
corpus callosum form a signiﬁcant obstacle to diﬀusion. Diﬀusion is more likely to occur parallel to the white matter ﬁbers as opposed to
perpendicular to them, and thus the shape of diﬀusion is ellipsoidal in these voxels.
Three of the more common diﬀusivity indices that have
beenexaminedintheDTIliteraturearefractionalanisotropy
(FA),meandiﬀusivity(MD),and,morerecently,Mode.FAis
a measure of the sphericity of the diﬀusion ellipsoid. FA can
vary between values of zero and one, with completely spheri-
cal diﬀusion having a value of zero and perfectly aspherical
(e.g., linear) diﬀusion having a value of one. In a WM
bundle, reduced FA is generally assumed to reﬂect damage
to the axon membrane, reduced axonal myelination, reduced
axonal packing density, and/or reduced axonal coherence
[18], while increased FA has been suggested to reﬂect
supranormal levels of myelination or axonal sprouting [19].
On the other hand, MD is dependent on the volume of the
diﬀusion ellipsoid, that is, the average displacement of water
molecules as a result of diﬀu s i o ni nag i v e na m o u n to ft i m e .
MD is highest in tissues where there are few impediments to
water diﬀusion (e.g., CSF), and lowest in tissues where diﬀu-
sion is restricted at least one direction (e.g., WM). Although
FA and MD are (almost) mathematically independent, they
are generally found to be inversely related in the brain, such
that tissue showing highly anisotropic diﬀusion (such as
WM) generally shows low MD. Mode is a relatively recently
developed index that provides additional information in
terms of the 3D shape of the diﬀusion ellipsoid than that
provided by FA. Roughly speaking, for a given FA value,
Mode describes whether the diﬀusion ellipsoid is shaped
like a cylinder (i.e., having highly “tubular” anisotropy) or
like a disk (i.e., having highly “planar” anisotropy) [20].
When considered in combination with FA, the Mode of
ad i ﬀusion ellipsoid provides unique information as to
the microstructural features of the underlying WM. For
example, the presence of ﬁber crossings has been associated
with reductions in Mode [21, 22]. Hence, the ﬁnding that
schizophrenia patients show supranormal levels of Mode in
the corpus callosum has been argued to reﬂect a reduction in
the density of ﬁbers adjacent to this fasciculus [23].
3. White Matter Abnormalities in
Schizophrenia—DoThey Existand
WhatDoTheyMean?
The ﬁrst DTI study that investigated WM abnormalities in
patients with schizophrenia was performed by Buchsbaum
et al. [24] in 1998. Since that time, over 100 DTI studies
have been performed on patients with schizophrenia. By
far the most consistent ﬁnding has been of FA reductions
in the patients, with signiﬁcant reductions being reported
in the corpus callosum, superior longitudinal fasciculus,
inferior longitudinal fasciculus, arcuate fasciculus, uncinate
fasciculus, cingulum bundle, and fornix [13, 18, 23, 25–
47]. The observation of FA reductions in patients with
schizophrenia raises the question as to what are the phys-
iologic underpinnings of these FA abnormalities. Research
by Beaulieu [48] indicates that axonal membranes are
the primary determinant of anisotropic water diﬀusion in
ﬁber bundles, with axonal myelination also modulating
anisotropy to a signiﬁcant, albeit lesser, extent. Hence one
possibility is that the reduced FA observed in schizophrenia
patients is due to a pathologic reduction in the number
of neurons, and hence their associated axons. However,
there is little evidence to suggest a signiﬁcant reduction
in neuron number in the brains of schizophrenia patients4 Schizophrenia Research and Treatment
relative to healthy people [49]. By contrast, there is evidence
to suggest that the characteristic GM reductions observed
in schizophrenia patients are likely the result of a reduction
in the density of dendrites, spines, axon-terminals, and
neuroglia [50]. In light of this, an alternative possibility is
that the FA abnormalities in schizophrenia are caused by
damage to the myelin-sheaths of oligodendrocytes.
It has been demonstrated that myelin abnormalities
alone can result in signiﬁcant reductions in FA. For example,
Nair and colleagues [51] compared wild-type mice and
transgenic shiverer mice (who show abnormalities in myelin
but not to the axon membrane) and found that the
shiverer mice had signiﬁcantly decreased FA in the corpus
callosum. Furthermore, Song and colleagues [52]f o u n d
evidence indicating that it is possible to distinguish between
axonal damage and dysmyelination on the basis of the
distinctive patterns of diﬀusivity abnormalities induced by
these injuries. Speciﬁcally, Song et al. [52] demonstrated
that while the amount of diﬀusion perpendicular to the
principal orientation of the optic nerve (which they termed
“radial diﬀusivity”) was increased in shiverer mice with
severe dysmyelination, the amount of diﬀusion parallel to
the tract (“axial diﬀusivity”) was unaﬀected. Conversely,
Song et al. [53] demonstrated that axonal injury concurrent
with myelin preservation resulted in a decrease in axial
diﬀusivity but no change in radial diﬀusivity. The signiﬁ-
cance of these ﬁndings is clear in the context of a recent
study by Ashtari et al. [54] who found that schizophrenia
patients exhibited abnormally increased radial diﬀusivity
in the inferior longitudinal fasciculus, but no diﬀerence in
axial diﬀusivity, putatively indicating the presence of myelin
abnormalities but the absence of axonal abnormalities. And
ﬁnally, in an electron microscopy study (with a very short
postmortem delay of four to six hours), Uranova et al.
[55] reported evidence of oligodendrocyte degeneration and
myelin damage in the prefrontal cortex and caudate nucleus
of patients with schizophrenia. When taken in combination,
these results suggest that myelin abnormalities are at least
partially responsible for the FA reduction typically observed
in patients with schizophrenia. If myelin abnormalities are at
least partially responsible for the FA reductions in patients
with schizophrenia, then what causes these abnormalities?
Furthermore, what is the relationship (if any) between
the myelin abnormalities inferred with DTI and the GM
abnormalities that have been consistently observed in these
patients both in vivo and in vitro?
It is well established that one of the principal functions
of myelin is to increase the transmission velocity of action
potentials traveling along axons by increasing membrane
capacitance and reducing ion leakage through the axon
membrane[8].Furthermore,thereisevidencetosuggestthat
diﬀusivity indices are correlated with indices of conduction
velocity measured via electroencephalography. For example,
Whitford and colleagues [56] found a signiﬁcant negative
correlation between the FA of the visual ﬁbers of the
corpus callosum and interhemispheric transfer time as mea-
sured with visually evoked potentials in both schizophrenia
patients and healthy controls. Given the evidence indicating
that patients with schizophrenia exhibit myelin abnormal-
ities in at least some WM bundles, particularly in those
bundles that connect the frontal lobe with the rest of the
brain, it seems reasonable to assume that this would result
in signiﬁcant transmission delays in neural communication
between spatially disparate GM regions, such as between the
frontal lobe and the temporal cortex (see [57]). And as has
been pointed out by both Fields [11]a n dA b o i t i z[ 58]e v e n
small transmission delays resulting from damaged myelin
could severely disrupt the synchronicity of disparate GM
regions.
In light of this, it is notable that several studies have
reported evidence of abnormal synchrony in the electroen-
cephalogram (EEG) in patients with schizophrenia [59, 60].
This ﬁnding is particularly salient given the role that neural
synchrony has been proposed to play in perceptual (and pos-
sibly cognitive) integration—abilities that are ubiquitously
aberrant in patients with schizophrenia. Recent work into
the functional role of the N-methyl D-aspartate- (NMDA-)
receptor has also led to increased interest in terms of the role
of neural synchronization in the etiology of schizophrenia.
The NMDA receptor is distinctive in that it is both ligand
and voltage-gated [61]. That is, the receptor will only allow
cationinﬂuxifglutamateisboundtothereceptoratthesame
time as the postsynaptic membrane is depolarized. Given its
distinct physiology, the NMDA-receptor has been implicated
asa“synchronydetector”thatmayplayaroleindetermining
which synapses are eliminated during development [62].
More speciﬁcally, synchronous synaptic activity (which has
been associated with NMDA-receptor activation [63]) has
been suggested to result in synaptic preservation, while
asynchronous activity has been suggested to facilitate or even
promote synaptic pruning [64].
Taken together, these ﬁndings might be explained by
a speculative hypothesis as to the relationship between
the GM and WM abnormalities present in patients with
schizophrenia. The hypothesis, which has been described in
detail elsewhere [65], suggests that some cases of schizophre-
nia arise because of currently undetermined developmen-
tal/environmental triggers causing the abnormal expres-
sion of myelin-related genes during the normative peri-
pubescent period of myelination of the association cortices.
The resultant myelin is consequently structurally damaged
and hence functionally damaged in its ability to insulate
the axon membranes and increase conduction velocity.
This results in small but signiﬁcant transmission delays in
communications between spatially disparate GM structures.
These transmission delays result in a disruption in neural
synchronization, such as between primary neural discharges
and their corollaries [57]. This results in both the symptoms
of psychosis and the exaggerated synaptic pruning (possibly
mediated by the NMDA-receptor) in the GM regions con-
nected by this functionally retarded WM. In a similar vein,
Moises et al. [66] have suggested that there may be a causal
relationship between abnormalities in glial growth factors
and synaptic destabilization in patients with schizophrenia.
This theory is clearly speculative and should be treated
with caution in the absence of a great deal more empirical
evidence. However, if nothing else, this theory acts as
an example of how WM abnormalities could potentiallySchizophrenia Research and Treatment 5
underpin both the symptoms of schizophrenia and the GM
atrophy characteristic of the disease. Moreover, if the WM
abnormalitiesexhibitedbyschizophreniapatientsdidindeed
underlie their psychological and physiological pathologies,
then this could provide an alternative target for pharma-
cologic interventions. For example, if myelin abnormalities
were ultimately found to underlie the hyperdopaminergic
state characteristic of schizophrenia, which the results of Roy
[67] at least tentatively suggest, then targeting the root of
the problem with medications used to preserve WM (such as
those in development for the treatment of multiple sclerosis
[68]) would potentially provide a useful adjunct or even a
better alternative to the dopamine antagonists currently used
in antipsychotic pharmacotherapy. It has also been suggested
that the eﬃcacy of current antipsychotic medications may, at
least in part, be due to their eﬀects on periadolescent myeli-
nation [69]. The idea that pharmacotherapy could be used to
target the root cause of the abnormal neurochemical proﬁle
exhibited by patients with schizophrenia is a tantalizing
prospect,andonethatisworthyofpursuitintheyearsahead.
4. Conclusions
DTI is unique in its ability to investigate in vivo the
structuralintegrityofWMﬁberbundles,whichrepresentthe
neuroanatomical infrastructure for long-distance communi-
cation in the brain. The consistency of WM abnormalities
observed in schizophrenia patients via DTI has been one of
the factors underlying the emergent (or rather, re-emergent)
conceptualizationofschizophreniaasadisorderofabnormal
connectivity between spatially disparate brain structures.
This conceptualization provides a novel theoretical frame-
work in terms of the etiology of the disease and opens the
door for the development of novel diagnostic tools and novel
treatment. When considered in combination with other
biomedical tools tuned to diﬀerent aspects of brain phys-
iology (e.g., oxygenation with fMRI, neurochemistry with
nuclear magnetic resonance spectroscopy, electrodynamics
via EEG, genetic proﬁle via microarray technology, etc.), the
development of DTI as a WM-imaging tool provides us with
an unprecedented opportunity to understand the root causes
of schizophrenia—an understanding that is necessary for
the targeted development of successful treatment programs.
The promise of new, knowledge-based breakthroughs in the
treatment of this devastating disorder makes this an exciting
time to be involved in schizophrenia research.
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